# Atezolizumab (Genetical Recombination) I.V. Infusion 1200mg (テセントリク点滴静注１２００ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291441A1024). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291441A1024
- **Product name (Japanese):** テセントリク点滴静注１２００ｍｇ
- **English title:** Atezolizumab (Genetical Recombination) I.V. Infusion 1200mg
- **Active ingredient:** アテゾリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Atezolizumab (Genetical Recombination)
- **Strength / unit:** １，２００ｍｇ２０ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Chugai Pharmaceutical (中外製薬)
- **NHI price (reference only):** JPY 563917 per １，２００ｍｇ２０ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291441A1024
- **JSON:** https://www.nifujipharma.com/api/drugs/4291441A1024

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Atezolizumab%20(Genetical%20Recombination)%20I.V.%20Infusion%201200mg%20(%E3%83%86%E3%82%BB%E3%83%B3%E3%83%88%E3%83%AA%E3%82%AF%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%EF%BC%91%EF%BC%92%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291441A1024#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Atezolizumab (Genetical Recombination)

- [Atezolizumab (Genetical Recombination) I.V. Infusion 840mg (テセントリク点滴静注８４０ｍｇ)](https://www.nifujipharma.com/drugs/4291441A2020) — ８４０ｍｇ１４ｍＬ１瓶, Chugai Pharmaceutical